2
Clinical Trials associated with JNJ-88545223A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of JNJ-88545223 For the Treatment of Participants With Active Psoriatic Arthritis
The purpose of this study is to evaluate how well the study drug JNJ-88545223 works compared with a placebo (an inactive substance) in adults with active psoriatic arthritis (PsA). The study aims to see whether treatment with JNJ-88545223 can help reduce the signs and symptoms of PsA and improve joint and skin health.
/ Not yet recruitingPhase 2IIT A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-rangingStudy to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants with Active Psoriatic Arthritis
100 Clinical Results associated with JNJ-88545223
100 Translational Medicine associated with JNJ-88545223
100 Patents (Medical) associated with JNJ-88545223
100 Deals associated with JNJ-88545223